ACTIVATION OF LYMPHOCYTE POPULATIONS EXPRESSING NKG2D USING ANTI-NKG2D ANTIBODIES AND LIGAND DERIVATIVES

Details for Australian Patent Application No. 2002255583 (hide)

Owner FRED HUTCHINSON CANCER RESEARCH CENTER, INC.

Inventors SPIES, Thomas; SPIES, Veronika

Pub. Number AU-A-2002255583

PCT Pub. Number WO2002/068615

Priority 60/272,408 28.02.01 US

Filing date 21 February 2002

Wipo publication date 12 September 2002

International Classifications

C12N 005/08 Undifferentiated human, animal or plant cells, e.g. cell lines -

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 039/00 Medicinal preparations containing antigens or antibodies

A61K 035/14 Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61P 035/00 Antineoplastic agents

A61P 031/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 037/00 Drugs for immunological or allergic disorders

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-A-2002255583

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002255584-Membrane separation for sulfur reduction

2002255582-STAMPED BIPOLAR PLATE FOR PEM FUEL CELL STACK